Effect of Vitamin D in Burn Patients

August 7, 2019 updated by: Hee Yeong Kim, Hangang Sacred Heart Hospital

Effect of Vitamin D in Burn Patients: A Randomized Clinical Trial

The purpose of this study is to evaluate pre-operative vitamin D levels in patients with burn injuries and evaluate the effect of vitamin D on postoperative complications and duration of hospitalization.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

Vitamin D deficiency often occurs in burn patients, which may include longer hospitalization and respiratory and cardiac complications.

The purpose of this study is to evaluate pre-operative vitamin D levels in patients with burn injuries and evaluate the effect of vitamin D on postoperative complications and duration of hospitalization.

Study Type

Interventional

Enrollment (Anticipated)

264

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Seoul, Korea, Republic of, 07247
        • Recruiting
        • Hangang Sacred Heart Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • vitamin D <30 ng/ml
  • patients undergoing burn surgery

Exclusion Criteria:

  • age < 18 years old
  • hypercalcemia
  • renal disease
  • cardiac disease ( EF<40%, MI, angina)
  • respiratory disease (ARDS, pneumonia)
  • intubated patients
  • electrical burn

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Vitamin D group
Vitamin D 200,000 IU (1 cc) IM
Vitamine D
Placebo Comparator: Control group
Normal saline 1 cc IM
Vitamine D

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of postoperative complications
Time Frame: Within postoperative 1 month
Infection, cardiovascular complication, gastrointestinal complication, respiratory complication, renal complication, and death
Within postoperative 1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Vitamin D level
Time Frame: Within postoperative 14 days
Serum 25-hydroxy vitamin D level
Within postoperative 14 days

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hospital stay
Time Frame: Time from operation to discharge (approximately within 1 month)
Length of hospital stay
Time from operation to discharge (approximately within 1 month)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 18, 2019

Primary Completion (Anticipated)

August 1, 2019

Study Completion (Anticipated)

October 1, 2019

Study Registration Dates

First Submitted

March 13, 2019

First Submitted That Met QC Criteria

March 19, 2019

First Posted (Actual)

March 21, 2019

Study Record Updates

Last Update Posted (Actual)

August 9, 2019

Last Update Submitted That Met QC Criteria

August 7, 2019

Last Verified

August 1, 2019

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Burn Surgery

Clinical Trials on Vitamin D

3
Subscribe